AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) solutions for wireless communications. Established in 2016, the company develops innovative error correction decoders designed for various markets, including mobile handsets, base stations, and satellite communications. Its product offerings include Polar, Turbo Decoder, and LDPC encoding/decoding chains, which are compliant with 3GPP standards. AccelerComm's technology addresses performance bottlenecks in next-generation wireless communication by enhancing the error correction processes necessary to mitigate the impacts of noise, interference, and poor signal strength. By providing cost-effective and high-performance solutions, AccelerComm enables clients to optimize their digital communication systems.
Legislate Technologies is transforming the way people enter contracts and negotiate terms in a transparent, efficient and fair way.
Opsydia Limited specializes in innovative laser marking technology that enables the creation of invisible structures within transparent materials. Founded in 2017 and based in Begbroke, United Kingdom, the company’s technology allows for the permanent and inimitable marking of serial numbers, images, and cryptographic data without altering the surface or compromising the integrity of materials like diamonds, glass, and polymers. This capability positions Opsydia to significantly enhance security and authenticity in various industries, particularly in diamond trading where identity verification is crucial. By embedding marks that are not visible to the naked eye, Opsydia's solutions provide a unique advantage in safeguarding valuable assets and improving overall material quality.
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that specializes in developing sustainable agricultural technologies. Founded in 2017 as a spin-out from the University of Oxford, the company focuses on discovering new herbicide chemistries with innovative modes of action derived from both natural and synthetic sources. By utilizing a proprietary in vivo plant-based genomic process, MoA Technology identifies specific target proteins linked to these new modes of action, thus providing farmers with a diverse range of effective weed control solutions. The company's approach aims to enhance food production while promoting sustainable crop systems.
Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices designed to address various autonomic and rhythmical bodily processes, including peristalsis, heart rate, and walking. Founded in 2016 and based in Bath, United Kingdom, the company leverages unique, patent-protected chip technology to create artificial Central Pattern Generators (CPGs). These CPGs aim to mimic natural nerve centers in the body, offering potential therapeutic solutions for individuals whose physiological functions have been compromised due to disease or injury. Ceryx Medical's innovative approach seeks to restore normal bodily performance, particularly in the context of conditions such as heart failure.
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
LettUs Grow, founded in 2015 and based in Bristol, United Kingdom, specializes in aeroponic irrigation and control technology designed for indoor farming. The company offers innovative aeroponic hardware that allows plants to grow without soil by using a fine mist for watering, complemented by LED lighting for photosynthesis. This technology aims to enhance the efficiency and sustainability of vertical farms while significantly reducing waste and carbon footprints. LettUs Grow has demonstrated notable yield improvements and is in the process of establishing Europe's first commercial-scale aeroponic vertical farm. The company is also expanding its capabilities and exploring global market opportunities, which are projected to grow at 27% annually. Its partnerships include various organizations such as the University of Bristol and Bethnal Green Ventures, reflecting a strong commitment to advancing sustainable food production in urban settings.
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy. The company develops both cell therapy and small molecule therapeutics primarily targeting cancer.
Sano Genetics is a user-centric genetic data marketplace that connects individuals directly to the research world. It act as ethical brokers to facilitate a direct connection between you and research institutions. The company was founded in 2017 and is headquartered in Cambridge.
BibliU is a digital educational service designed to enhance the learning experience for university students. It provides access to a vast library of textbooks and monographs, allowing students to search for relevant materials easily. The platform also facilitates interaction among students and professors, promoting collaborative learning and engagement. By streamlining access to educational content, BibliU aims to make the learning process more efficient and effective.
SERG Technologies is focused on transforming the interaction between individuals and technology through the development of advanced wearables and a digital health platform. Their innovative sensors capture subtle, subconscious movements to generate control signals for various devices, allowing for efficient operation of smart technology. Additionally, SERG is dedicated to improving the lives of individuals with Parkinson's and other neurodegenerative movement disorders by providing tools for continuous and personalized symptom assessment. This platform delivers actionable insights that aid in optimizing medication and treatment plans, empowering patients to better manage their conditions and enhance their mobility and independence. Through these initiatives, SERG Technologies aims to make gesture control and health monitoring more accessible and user-friendly for all.
Modern graphical user interface design uses a set of reusable components to create intuitive interactions. Here at OWidgets we aim to create a similar set of components for olfactory interactions, fully exploiting the properties of the sense of smell - Olfactory Widgets.
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs.
Barocal is a Zero-carbon refrigeration.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board fuel cells (PCBFCs). Leveraging its expertise in the high-volume printed circuit board industry, the company produces a range of fuel cell products, including 20 W, 500 W, and 5 kW PCBFC stacks, as well as custom-designed solutions. Bramble Energy aims to supply gigawatts of fuel cell hardware, positioning itself as a leader in the energy technology sector. Its innovative approach caters to various applications across the stationary, portable, automotive, and mobility sectors. Founded in 2015, Bramble Energy is focused on delivering high-performance and cost-effective fuel cell solutions.
Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, specializing in tissue regenerative implants for patients with knee injuries. Founded in 2008 by Dr. Nick Skaer and Professor Oliver Kessler, the company leverages silk technology developed at Oxford University to create innovative solutions for cartilage and meniscus repair. Its primary products include FibroFix, a biomaterial designed to replicate human knee cartilage; FibroFix Meniscus, which focuses on repairing and regenerating meniscal cartilage; and FibroFix Cartilage, aimed at treating articular cartilage damage. The technology behind these products was originally developed at Oxford Biomaterials Ltd., where Dr. Skaer played a significant role in advancing the FibroFix technology platform before securing exclusive licenses for its application in cartilage and bone repair.
Sano Genetics is a user-centric genetic data marketplace that connects individuals directly to the research world. It act as ethical brokers to facilitate a direct connection between you and research institutions. The company was founded in 2017 and is headquartered in Cambridge.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.
Diffblue is changing the way software is developed using Artificial Intelligence (AI).
Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification and synthesis, and customers include Goldman Sachs and Amazon Web Services.
Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK.
Cambridge Touch Technologies Ltd. is a company based in Cambridge, United Kingdom, founded in 2011. It specializes in the development of piezoelectric-based 3D touch technology, particularly its next-generation UltraTouch technology, which is designed for smart devices, including smartphones, tablets, and automotive applications. The UltraTouch system integrates a proprietary AI engine that utilizes advanced signal processing algorithms with a specialized Piezoelectric Force Film. This innovative combination allows for a versatile touch and force sensor architecture that is not only cost-effective but also adaptable to various device sizes and shapes, including curved and foldable designs.
Stent Tek Ltd. is a London-based company founded in 2014 that specializes in developing a catheter-based system for patients undergoing haemodialysis due to kidney failure. The company focuses on providing minimally invasive vascular access solutions through the use of a synthetic connector tube, also known as a covered stent. This innovative approach aims to improve the quality of care for dialysis patients by facilitating easier and safer access to blood vessels. Stent Tek Ltd. operates within a significant market, addressing the needs of a growing population requiring dialysis treatment.
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
Fuel3D is a company that specializes in affordable handheld 3D scanning technology, aimed at providing high-quality 3D shape and color capture for various creative applications. The Fuel3D scanner is a point-and-shoot device that utilizes pre-calibrated stereo cameras combined with photometric imaging to quickly capture high-resolution mesh and color information of objects. This innovative approach addresses the common challenges of time and cost associated with generating quality 3D images, which often exceed $15,000 for traditional scanners, making them inaccessible for many independent developers and artists. Originally developed at Oxford University for medical imaging, Fuel3D's technology is now being adapted for the broader 3D market, with the intention of making point-and-shoot 3D imaging accessible to both consumers and professionals. The company is led by Stuart Mead, who brings extensive experience from various successful technology ventures.
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions.
Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Developer of health care devices designed to help people with Parkinson's improve their quality of life. The company develops a non-invasive wearable device that modulates sensory dysfunction, helping people with Parkinson's disease to improve their movement speed while living a normal life.
Carbon Re specializes in the decarbonization of high-emission industries, focusing on sectors such as cement, steel, metals, bulk chemicals, glass, paper, and ceramics. The company has developed a cloud-based Foundation Platform that integrates advanced continuous improvement techniques with artificial intelligence. This platform aims to enhance operational efficiencies while significantly reducing greenhouse gas emissions in manufacturing processes. By leveraging this technology, Carbon Re enables its clients to achieve reductions in emissions of up to 20%, resulting in substantial savings on electricity, fuel, and carbon costs for each plant annually.
Zetta Genomics is a Cambridge-based company established in 2018 that focuses on managing large-scale genomic data to advance precision medicine. The company operates a user-centric platform that facilitates connections between individuals and researchers, allowing users to opt in or out of studies related to various health conditions, including common disorders like eczema and diabetes, as well as rare diseases such as muscular dystrophy. By employing distributed database technology and robust security measures, Zetta Genomics ensures the privacy of genomic data while enabling scientists to access dynamic health and genetic datasets for personalized medicine research. The platform emphasizes transparency and control for users throughout the data-sharing process.
Cheesecake Energy is developing advanced thermal and compressed air energy systems to store energy from intermittent renewables, turning them into reliable power on-demand.
PetMedix Ltd is a veterinary biopharmaceutical company based in Cambridge, UK, focused on developing therapeutic drug discovery tools and platforms for pets. Founded in 2017, the company specializes in creating transgenic mouse platforms, such as Ky9 and Felyne, which produce therapeutic-quality antibody drugs specifically tailored for companion animals. Leveraging over thirty years of expertise in human drug development, PetMedix aims to generate a diverse repertoire of monoclonal antibodies that aligns with the immune systems of pets. This innovation enables veterinary professionals to provide effective and safe treatments, ultimately contributing to the health and well-being of animals.
Developer of perovskite-based display materials intended to secure fundamental IP with a strong, scientific foundation. The company's technologies are based on the use of innovative new materials built around metal halide perovskites which can be synthesized from low-temperature alternative processes using earth-abundant precursor materials, enabling scientists to get bright and colorful light-emitting materials and technologies for TV and displays.
Nozzle.ai is an eCommerce and advertising optimization platform focused on enhancing sales for online sellers, particularly on Amazon. The company provides a suite of services, including marketplace audits, advertisement optimization, and consulting. Utilizing data science, Nozzle.ai analyzes customer buying patterns to deliver insights on key metrics such as customer repeat order rates, lifetime value, and customer acquisition costs. This data-driven approach enables online sellers and agencies to improve their advertising strategies, ultimately increasing sales and revenue. Founded in 2014 and headquartered in London, Nozzle.ai operates under the umbrella of Beeswax, Inc. after rebranding from MediaGamma Limited in May 2020. The company's offerings also include artificial intelligence consultancy, machine learning operations, and various support services for setting up and managing advertising campaigns.
CB2Tech is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications.
Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, that specializes in the development and manufacture of lithium-ion batteries for mobile devices and the automotive industry. Founded in 2017 as a spinout from the University of Cambridge Engineering Department, Echion leverages proprietary battery active materials to create next-generation batteries. The company's focus is on producing anode materials designed to facilitate fast charging for electric vehicles, promoting sustainable electrification across various applications. By optimizing power anode materials, Echion aims to provide cost-effective solutions for battery production, contributing to a more sustainable future in energy storage and usage.
Bonnet Ltd., founded in 2019 and based in London, develops a charging-as-a-service platform that simplifies access to public electric vehicle chargers. The company aims to alleviate the inconvenience faced by drivers who must register for multiple charging networks. Bonnet offers a subscription service that enables users, both individuals and businesses, to utilize any public charger through a single account. The platform not only provides access to a comprehensive network of charging points across Europe but also features real-time charger availability information and contactless payment options. This approach enhances the user experience while promoting a more visible and accessible charging infrastructure for businesses.
Private Equity Round in 2021
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally.
We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times.
Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
Lumenisity specializes in developing innovative hollow-core fiber optic cable solutions to meet the growing demand for high-capacity communications systems. Established in 2016 to commercialize advanced research and development from the University of Southampton, the company focuses on addressing the bandwidth limitations faced by the data telecom market. By offering cutting-edge hollow-core optical fiber cables, Lumenisity aims to enhance communication networks, providing significant improvements in bandwidth connectivity. The company is supported by a consortium of industrial and private investors and is actively expanding its team and infrastructure to further its capabilities.
Fresh Check is a company focused on food safety through innovative technology. Its primary product is a color-changing sticker designed to be placed inside food packaging, which indicates when the food has spoiled, rather than relying solely on the use-by date. In addition to this, Fresh Check also develops hygiene testing solutions that detect bacterial contamination on surfaces. These testing products are applicable in various sectors, including food, hospitality, and healthcare, allowing businesses to demonstrate their commitment to hygiene and food safety. By offering cost-effective methods for identifying contamination, Fresh Check supports clients in maintaining high standards of cleanliness and safety in their operations.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
PredictImmune Ltd is a company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. Its primary product, PredictSURE IBD, is designed to guide treatment options for patients with Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis. This innovative test utilizes a small blood sample to accurately identify patients at the time of diagnosis who are at risk for severe, relapsing disease. By providing essential information regarding long-term clinical prognosis, the test supports healthcare professionals in determining personalized treatment plans, particularly the timely use of biologics therapy. PredictImmune's approach is recognized as beneficial by physicians, patients, and payors, as it enhances the management of Inflammatory Bowel Disease and improves patient outcomes.
Versed AI is a company that specializes in supply chain intelligence, offering a SaaS-based platform that utilizes advanced natural language processing and machine learning techniques. The platform is designed to automatically extract and visualize supply chain maps from various text documents, enabling organizations to monitor, manage, and mitigate risks within their supply chains. By identifying buyer-supplier relationships and potential points of failure, Versed AI provides valuable insights that help companies optimize their supply chain operations. Founded by Simon Baker and Fenelle Boyle, the company focuses on delivering actionable intelligence to enhance supply chain resilience and efficiency.
Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.
Mogrify is a UK biotechnology company focused on advancing ex vivo cell therapies and developing innovative in vivo reprogramming therapies. It has created a proprietary platform that enables the direct conversion of mature cell types into other mature states without reverting to a stem cell stage, significantly improving the efficiency of stem cell-derived reprogramming. Mogrify aims to create a consistent and scalable source of cell types with the necessary efficacy and safety profiles for treating various high unmet clinical needs, particularly in oncology and ophthalmology. The company’s technology is protected by a foundational patent and additional applications that cover specific cell conversions. Mogrify employs a business model that includes internal cell therapy development, co-development partnerships, and licensing agreements for its novel cell conversions, targeting the expanding regenerative medicine market. Founded in 2016, Mogrify is headquartered in Cambridge, United Kingdom.
Kvasir Analytics is an AI knowledge management software company.
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
Abselion specializes in the development of biosensors aimed at enhancing the analysis of biological substances, such as proteins and small molecules, for pharmaceutical research and manufacturing. The company's innovative diagnostic analyzers and kits facilitate the study of biomolecular interactions, including protein interaction analysis. By providing a rapid and cost-effective means of detecting biological materials, Abselion enables researchers to achieve sensitive and near real-time medical diagnoses, thereby simplifying the analytical processes essential for advancing pharmaceutical research.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.
Carbometrics is a specialized chemistry company focused on the development of glucose-binding molecules aimed at improving the lives of individuals with diabetes. Leveraging over 20 years of research led by Professor Anthony Davis at the University of Bristol, Carbometrics designs, synthesizes, and modifies carbohydrate-binding molecules to create a highly accurate and robust glucose sensing platform. The company's primary objective is to utilize its glucose-binding molecule technology to develop a market-leading Continuous Glucose Monitoring (CGM) solution. Founded by the team behind the successful company Ziylo, which was acquired by Novo Nordisk, Carbometrics aims to advance diabetes management through innovative monitoring solutions.
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
PhoreMost Limited, a drug discovery company, engages in identifying new druggable targets for cancer and other unmet diseases. It develops Site-Seeker, a platform that systematically unmasks druggable sites in the human genome and links them to useful therapeutic functions in a live-cell context. The company was incorporated in 2014 and is based in Cambridge, United Kingdom.
Riverlane is the most advanced quantum computing software developer
Entia Ltd is a medical technology company based in London, United Kingdom, that focuses on enhancing access to blood tests through innovative healthcare devices. Founded in 2014, Entia offers two primary products: Aptus, a device for testing haemoglobin and haematocrit levels, and Affinity, designed for cancer patients to monitor their blood counts from home. These devices facilitate health screening, blood donor screening, maternal and child health, nutrition, and sports applications, while also enabling cancer patients to manage their health more effectively, reducing the risk of infection and minimizing hospital visits. The company employs a multidisciplinary team that encompasses design, engineering, quality assurance, and business development, all aimed at improving patients' quality of life by allowing them to conduct essential health monitoring from the comfort of their homes.
Cytoseek Limited, founded in 2017 and based in Bristol, United Kingdom, specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. As a spinout from the University of Bristol, the company utilizes a unique cell membrane augmentation technology that enhances cell therapies by adding new functionalities, such as tissue-specific targeting and improved cell survivability. Currently, Cytoseek is conducting proof of principle studies to validate the effectiveness of its therapies and is actively seeking partnerships with other cell therapy companies to advance these treatments into clinical settings, ultimately aiming to improve human health.
Legislate Technologies is transforming the way people enter contracts and negotiate terms in a transparent, efficient and fair way.
Cambridge GaN Devices is a developer of semiconductors focused on designing, creating, and commercializing gallium nitride-based power devices. The company's transistors offer higher speed, significantly lower power loss, and reduced size compared to traditional silicon alternatives. These advancements result in lower energy consumption and enhanced power storage and conversion capabilities. As a result, Cambridge GaN Devices provides industries with compact semiconductors tailored for critical applications across various market segments.
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.
Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions.
Mirriad currently operates in the US, Europe and China.
Phasecraft Limited is a UK-based company founded in 2018 that specializes in developing quantum software for quantum information processors, including intermediate-scale devices and quantum computers. The company focuses on creating algorithms that enable clients to address complex challenges in various industries, such as discovering new catalysts and optimizing key industrial processes. By leveraging its software, Phasecraft aims to enhance the practical application of quantum computing, allowing clients to explore innovative quantum materials and improve the efficiency of technologies like batteries and solar cells.
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market. The company specializes in rapid set liquid barriers.
Nozzle.ai is an eCommerce and advertising optimization platform focused on enhancing sales for online sellers, particularly on Amazon. The company provides a suite of services, including marketplace audits, advertisement optimization, and consulting. Utilizing data science, Nozzle.ai analyzes customer buying patterns to deliver insights on key metrics such as customer repeat order rates, lifetime value, and customer acquisition costs. This data-driven approach enables online sellers and agencies to improve their advertising strategies, ultimately increasing sales and revenue. Founded in 2014 and headquartered in London, Nozzle.ai operates under the umbrella of Beeswax, Inc. after rebranding from MediaGamma Limited in May 2020. The company's offerings also include artificial intelligence consultancy, machine learning operations, and various support services for setting up and managing advertising campaigns.
Congenica Ltd. is a UK-based company that specializes in clinical data solutions for genetic diagnosis. Founded in 2012, it leverages pioneering research from the Wellcome Trust Sanger Institute and NHS clinicians to develop its flagship product, the Sapientia platform. This clinical genomic analytics tool integrates human DNA sequences with deep clinical phenotyping, allowing clinicians and researchers to interpret genetic diseases effectively. Sapientia supports clinical diagnosis, prognosis, and research, and plays a crucial role in personalized medicine applications, including the creation of disease registries and the identification of patient populations for clinical studies. By providing diagnostic decision support and associated services, Congenica aims to enhance patient care through precise diagnoses and the curation of evolving knowledge bases, ultimately contributing to advancements in clinical trials and drug development.
Phasecraft Limited is a UK-based company founded in 2018 that specializes in developing quantum software for quantum information processors, including intermediate-scale devices and quantum computers. The company focuses on creating algorithms that enable clients to address complex challenges in various industries, such as discovering new catalysts and optimizing key industrial processes. By leveraging its software, Phasecraft aims to enhance the practical application of quantum computing, allowing clients to explore innovative quantum materials and improve the efficiency of technologies like batteries and solar cells.
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
1715Labs is a company being established to commercialise Zooniverse technology.
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that specializes in developing sustainable agricultural technologies. Founded in 2017 as a spin-out from the University of Oxford, the company focuses on discovering new herbicide chemistries with innovative modes of action derived from both natural and synthetic sources. By utilizing a proprietary in vivo plant-based genomic process, MoA Technology identifies specific target proteins linked to these new modes of action, thus providing farmers with a diverse range of effective weed control solutions. The company's approach aims to enhance food production while promoting sustainable crop systems.
GeoSpock Limited is a spatial big data platform company based in Cambridge, United Kingdom, with additional offices in Tokyo and Singapore. Founded in 2013, it specializes in developing a data indexing platform that provides analytics, visualization, and insights across various scales of data. The company offers products such as GeoSpock DB Discovery and GeoSpock DB Enterprise, which are cloud-based services designed to manage and analyze location-tagged information. These tools facilitate dynamic data fusion and enable users to perform complex queries for performance analytics. GeoSpock's platform can be utilized in a range of applications, from real-time tracking of logistics fleets to optimizing operations in smart cities, helping to uncover hidden patterns and improve decision-making. By harnessing trillions of data points in seconds, GeoSpock aims to transform business operations and contribute to sustainability efforts, such as reducing traffic congestion.
Lumenisity specializes in developing innovative hollow-core fiber optic cable solutions to meet the growing demand for high-capacity communications systems. Established in 2016 to commercialize advanced research and development from the University of Southampton, the company focuses on addressing the bandwidth limitations faced by the data telecom market. By offering cutting-edge hollow-core optical fiber cables, Lumenisity aims to enhance communication networks, providing significant improvements in bandwidth connectivity. The company is supported by a consortium of industrial and private investors and is actively expanding its team and infrastructure to further its capabilities.
CB2Tech is a developer of high-power battery technology used to serve automotive applications. It researches and develops battery technology that could have a higher power, recharge at a faster speed and store large amounts of energy that helps the automotive industry with solutions for high-power applications.
GeoSpock Limited is a spatial big data platform company based in Cambridge, United Kingdom, with additional offices in Tokyo and Singapore. Founded in 2013, it specializes in developing a data indexing platform that provides analytics, visualization, and insights across various scales of data. The company offers products such as GeoSpock DB Discovery and GeoSpock DB Enterprise, which are cloud-based services designed to manage and analyze location-tagged information. These tools facilitate dynamic data fusion and enable users to perform complex queries for performance analytics. GeoSpock's platform can be utilized in a range of applications, from real-time tracking of logistics fleets to optimizing operations in smart cities, helping to uncover hidden patterns and improve decision-making. By harnessing trillions of data points in seconds, GeoSpock aims to transform business operations and contribute to sustainability efforts, such as reducing traffic congestion.
Congenica Ltd. is a UK-based company that specializes in clinical data solutions for genetic diagnosis. Founded in 2012, it leverages pioneering research from the Wellcome Trust Sanger Institute and NHS clinicians to develop its flagship product, the Sapientia platform. This clinical genomic analytics tool integrates human DNA sequences with deep clinical phenotyping, allowing clinicians and researchers to interpret genetic diseases effectively. Sapientia supports clinical diagnosis, prognosis, and research, and plays a crucial role in personalized medicine applications, including the creation of disease registries and the identification of patient populations for clinical studies. By providing diagnostic decision support and associated services, Congenica aims to enhance patient care through precise diagnoses and the curation of evolving knowledge bases, ultimately contributing to advancements in clinical trials and drug development.
Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices designed to address various autonomic and rhythmical bodily processes, including peristalsis, heart rate, and walking. Founded in 2016 and based in Bath, United Kingdom, the company leverages unique, patent-protected chip technology to create artificial Central Pattern Generators (CPGs). These CPGs aim to mimic natural nerve centers in the body, offering potential therapeutic solutions for individuals whose physiological functions have been compromised due to disease or injury. Ceryx Medical's innovative approach seeks to restore normal bodily performance, particularly in the context of conditions such as heart failure.
Nu Quantum Ltd is a Cambridge-based company that specializes in the development of quantum photonics hardware, including photon sources and detectors, as well as quantum cryptography systems. Founded in 2018, the company focuses on creating nano-engineered materials that facilitate light generation at the quantum level and enable ultra-sensitive light detection. It also develops fundamental algorithms and protocols for generating secure cryptographic keys and offers quantum encryption links for secure communications. By integrating novel materials and semiconductor technology, Nu Quantum aims to provide end-to-end quantum cryptography solutions that secure communications over urban and satellite free-space optical links, thereby supporting the future of information processing and quantum networking infrastructure.
GaitQ is a developer of a medical device used to help people living with Parkinson's disease to overcome freezing of gait. Its small, portable device uses clinically proven sensory cues that enable patients to re-establish the connection between the brain and the body helps the patients to walk smoothly again.
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board fuel cells (PCBFCs). Leveraging its expertise in the high-volume printed circuit board industry, the company produces a range of fuel cell products, including 20 W, 500 W, and 5 kW PCBFC stacks, as well as custom-designed solutions. Bramble Energy aims to supply gigawatts of fuel cell hardware, positioning itself as a leader in the energy technology sector. Its innovative approach caters to various applications across the stationary, portable, automotive, and mobility sectors. Founded in 2015, Bramble Energy is focused on delivering high-performance and cost-effective fuel cell solutions.
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board fuel cells (PCBFCs). Leveraging its expertise in the high-volume printed circuit board industry, the company produces a range of fuel cell products, including 20 W, 500 W, and 5 kW PCBFC stacks, as well as custom-designed solutions. Bramble Energy aims to supply gigawatts of fuel cell hardware, positioning itself as a leader in the energy technology sector. Its innovative approach caters to various applications across the stationary, portable, automotive, and mobility sectors. Founded in 2015, Bramble Energy is focused on delivering high-performance and cost-effective fuel cell solutions.
Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices designed to address various autonomic and rhythmical bodily processes, including peristalsis, heart rate, and walking. Founded in 2016 and based in Bath, United Kingdom, the company leverages unique, patent-protected chip technology to create artificial Central Pattern Generators (CPGs). These CPGs aim to mimic natural nerve centers in the body, offering potential therapeutic solutions for individuals whose physiological functions have been compromised due to disease or injury. Ceryx Medical's innovative approach seeks to restore normal bodily performance, particularly in the context of conditions such as heart failure.
Mind Foundry Limited, founded in 2015 and based in Oxford, United Kingdom, specializes in developing software that empowers organizations to extract valuable insights from their data. Established by Professors Stephen Roberts and Michael Osborne, the company leverages advanced machine learning and algorithmic modeling techniques to address complex challenges across various sectors. Mind Foundry's platform is designed to be both powerful and user-friendly, making machine learning accessible to individuals within organizations, not just data scientists. This approach enables teams to utilize data effectively, enhancing decision-making and driving business success. By fostering collaboration between AI and humans, Mind Foundry aims to help organizations unlock the potential of their data to tackle significant global issues.
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.
Qkine Ltd, founded in 2016 and based in Cambridge, United Kingdom, specializes in the manufacturing of high-purity, animal-derived component-free (ADCF) growth factors and cytokines. The company emerged from Cambridge University and focuses on providing proteins for stem cell growth, differentiation, and regenerative medicine applications. Utilizing advanced protein engineering and optimized production platforms, Qkine addresses supply chain challenges in stem cell science by delivering novel, animal-free proteins. Their products support life science research, particularly in stem cell and organoid culture, enabling scientists to advance their work with high-quality, bioactive proteins.
Oxford Flow Ltd. specializes in the design, manufacture, and supply of pressure control equipment, including gas regulators, water pressure reducing valves, silencers, and pilots. Established in 2015 and headquartered in Oxford, United Kingdom, the company serves a diverse range of industries such as water, gas, marine, oil and gas, process, power, and building services. Oxford Flow combines expertise from academia and industry to create practical solutions that enhance operational efficiency while minimizing environmental impact. Each of their products is developed through rigorous testing and customer feedback, ensuring reliability and performance in challenging conditions.
Flusso Ltd, established in 2016 and located in Cambridge, United Kingdom, specializes in the development of advanced flow sensors. Currently operating in stealth mode, the company is focused on creating the world's smallest flow sensor, utilizing fabless semiconductor technology to blend hardware, software, and mechanical components. Flusso's innovative sensors are designed to be significantly smaller and more cost-effective, while also enhancing functionality without sacrificing performance. This approach allows the flow sensing industry to benefit from lower power consumption, ultra-fast response times, on-chip multisensory integration, embedded intelligence, and the capability for high-volume production at reduced unit costs.
Fuel3D is a company that specializes in affordable handheld 3D scanning technology, aimed at providing high-quality 3D shape and color capture for various creative applications. The Fuel3D scanner is a point-and-shoot device that utilizes pre-calibrated stereo cameras combined with photometric imaging to quickly capture high-resolution mesh and color information of objects. This innovative approach addresses the common challenges of time and cost associated with generating quality 3D images, which often exceed $15,000 for traditional scanners, making them inaccessible for many independent developers and artists. Originally developed at Oxford University for medical imaging, Fuel3D's technology is now being adapted for the broader 3D market, with the intention of making point-and-shoot 3D imaging accessible to both consumers and professionals. The company is led by Stuart Mead, who brings extensive experience from various successful technology ventures.
Quantum Motion Technologies Limited is focused on developing a universal quantum computer utilizing silicon-based technology and CMOS-compatible processes. Founded in 2017 and based in Leeds, United Kingdom, the company aims to create scalable quantum computing architectures that address issues such as fault tolerance and qubit redundancy. Its technology is designed to enhance qubit density, allowing for the construction of large-scale quantum systems capable of solving complex problems in various fields, including chemistry, medicine, and artificial intelligence. By leveraging advanced architectural approaches, Quantum Motion Technologies seeks to advance the quantum technology sector and provide solutions that reduce errors and overcome critical challenges in quantum information processing.
PervasID Limited, founded in 2011 and based in Cambridge, United Kingdom, specializes in the development of wide area passive RFID systems. The company emerged from research conducted at the University of Cambridge and focuses on providing location capabilities based on the EPC Class1 Gen2 standard. PervasID's technology employs fixed ultra-high frequency RFID to accurately detect passive tags over long distances, facilitating enhanced visibility into goods, assets, and people. Its innovative systems are designed to serve various industries, including retail, healthcare, supply chain and logistics, and aviation. The technology has been successfully deployed in multiple field trials, demonstrating its reliability and effectiveness in streamlining processes across diverse markets.
Sorex Sensors Limited specializes in the design and manufacturing of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for both industrial and consumer applications. The sensors are constructed on silicon wafers and utilize a thin film of piezoelectric material, enabling them to measure mass by detecting changes in resonant frequency when mass is applied to their surface. These sensors are characterized by their dual-mode capability, allowing simultaneous measurement of mass and temperature, with mass sensitivity reaching the femtogram range and temperature resolution down to 0.2 °C. Their compact size and low power consumption make them suitable for various applications, including thin film metrology, particulate monitoring, and gas detection. Sorex Sensors was incorporated in 2017 and is headquartered in the United Kingdom.
Xampla Ltd develops and produces a pea plant protein-based plastic material to replace microplastics for commercial use. The company’s products include microcapsules for application in homecare and personal care products; and films, coatings, and single use plastics for application in single and multi-layer films, coatings, and packaging products. Xampla Ltd was incorporated in 2018 and is based in Cambridge, United Kingdom.
PharmEnable Limited is a drug discovery company based in Cambridge, United Kingdom, that was incorporated in 2016. The company specializes in using medicinal chemistry and artificial intelligence to design small molecule drugs. PharmEnable has developed a rapid and cost-effective method for identifying improved chemical starting points, which aims to enhance the discovery of essential new medicines.
Ilika is a company specializing in the design, development, and production of solid-state batteries, primarily based in the United Kingdom, with a presence in Asia, Europe, and North America. Founded in 2010 and headquartered in Romsey, Ilika offers a variety of battery solutions for diverse applications, including industrial Internet of Things (IoT), electric vehicles, smart cities, consumer electronics, medical devices, automotive, military, and aerospace sectors. The company is known for its innovative Stereax micro batteries, tailored for the Industrial IoT and MedTech markets, as well as its Goliath large format batteries aimed at electric vehicles and consumer electronics. Ilika's patented high-throughput techniques significantly accelerate the development of new materials for energy and electronics, enabling faster production and testing compared to traditional methods. Its Stereax technology presents several advantages over conventional lithium-ion batteries, such as a smaller footprint, higher energy density, non-toxic materials, quicker charging, longer cycle life, low leakage, and reduced flammability.
AudioTelligence Ltd is a company based in Cambridge, United Kingdom, founded in 2017, that specializes in real-time audio processing technology aimed at improving automatic speech recognition (ASR) systems. The company utilizes an innovative approach known as blind audio signal separation, which allows it to effectively distinguish target voices from background noise without relying on high-quality microphones. This technology enhances the clarity and intelligibility of audio, making it easier for humans and voice-activated devices to engage in conversations despite challenging acoustic environments. AudioTelligence's solutions outperform traditional methods such as beamforming and spectral masking, positioning the company as a leader in the field of audio enhancement.
Kalium Health Ltd is a company based in Cambridge, United Kingdom, that specializes in the design, development, and manufacturing of a finger-prick blood test for measuring blood potassium concentration. This innovative testing method allows patients to seek treatment proactively, avoiding the inconveniences, costs, and delays associated with traditional testing methods. Established in 2018 and formerly known as Kalium Diagnostics Ltd, the company focuses on personalized electrolyte diagnostics aimed at enhancing kidney care. By utilizing advanced electrolyte sensing technology, Kalium Health provides accurate and real-time testing that delivers clinically actionable health insights related to cardiorenal diseases, enabling patients to obtain precise blood electrolyte data for better health management.
Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, that specializes in the development and manufacture of lithium-ion batteries for mobile devices and the automotive industry. Founded in 2017 as a spinout from the University of Cambridge Engineering Department, Echion leverages proprietary battery active materials to create next-generation batteries. The company's focus is on producing anode materials designed to facilitate fast charging for electric vehicles, promoting sustainable electrification across various applications. By optimizing power anode materials, Echion aims to provide cost-effective solutions for battery production, contributing to a more sustainable future in energy storage and usage.
Ikarovec
Seed Round in 2020
Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
Manufacturer and developer of organic photovoltaic devices designed to enhance next-generation solar technology. The company's devices engage in the deployment of off-grid solar power and use advanced nanotechnology to split each incoming blue and green photon into two infra-red photons, enabling clients to deploy solar power through lightweight devices whenever needed.
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally.
We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times.
Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.
RoboK Limited, founded in 2017 and headquartered in Cambridge, United Kingdom, specializes in designing and developing simultaneous localization and mapping (SLAM) algorithms alongside 3D sensing solutions. The company focuses on software solutions that facilitate AI-based perception, aiming to enhance the deployment of affordable autonomy technologies for automotive and industrial applications. Its offerings include advanced 3D sensing technologies applicable to autonomous driving, vision-based sensing, sensor fusion, and machine automation. Additionally, RoboK provides a computer vision analytics platform that delivers actionable insights for large-scale transport and logistics infrastructure. This platform enables automotive and infrastructure companies to transform passive cameras into active engines for object detection, classification, tracking, and continuous localization in both indoor and outdoor settings.
Paragraf Ltd. is a graphene technology development company based in Somersham, United Kingdom, established in 2015. The company specializes in the production of two-dimensional materials, particularly graphene, and focuses on developing graphene-based electronic devices, green energy generation devices such as solar photovoltaic cells, and various sensors. By leveraging innovative methods, Paragraf aims to unlock the full potential of graphene and advance its applications across multiple technology sectors. The company's commitment to driving the adoption of this versatile material positions it as a key player in the field of advanced materials and their transformative capabilities.